Suchergebnisse
Suchergebnisse:
Stuart Schreiber ist eine der Hauptfiguren in dem Buch Das Milliarden Dollar Molekül in dem der Autor und Journalist Barry Werth die Gründung des amerikanischen Venture-capital -Unternehmens Vertex beschreibt. Werke. Neben mehr als 250 wissenschaftlichen Artikeln veröffentlichte er:
Stuart Schreiber is an American chemist who is the Morris Loeb Research Professor at Harvard University, a co-Founder of the Broad Institute, Howard Hughes Medical Institute Investigator, Emeritus, and a member of the National Academy of Sciences and National Academy of Medicine.
Stuart Schreiber is a Morris Loeb Professor of Chemistry and Chemical Biology, Emeritus, and a Howard Hughes Medical Institute Investigator. His lab studies the science of therapeutics, including drug discovery, cell signaling, gene regulation, and brain health.
Stuart Schreiber is a pioneer of chemical biology and a co-founder of the Broad Institute. He discovered molecular glues, PROTACs, and other small molecules that modulate biological processes and disease.
1. März 2024 · Stuart Schreiber, a chemist and co-founder of The Broad Institute, discusses his plans to tackle inefficiencies in the translation of biomedical research, through the newly launched for-profit institute Arena BioWorks. He explains how Arena aims to speed up the discovery and development of new medicines for diseases such as brain health, oncology and ageing.
- Asher Mullard
Stuart L. Schreiber1,2,*. 2021 marks the 30th anniversary of the revelation that cyclosporin A and FK506 act in a way previously not seen—as ‘‘molecular glues’’ that induce neo-protein–protein associations. As a torrent of new molecular-glue probes and medicines are fueling interest in this field, I explore the arc of this story.
The Schreiber lab led by Stuart Schreiber uses chemical biology and human biology to discover small-molecule probes and therapeutics for various diseases. Learn about their areas of focus, such as next-generation synthesis, cancer and microbial therapeutics, and novel mechanisms of action.
